526-21-6 Usage
General Description
Glycine,N-(2-aminobenzoyl)-, also known as N-(2-Boc-amino)-5-benzyloxyglycine, is a chemical compound that falls under the category of amino acids. It is a derivative of glycine with a benzoyl group attached to the nitrogen atom. Glycine,N-(2-aminobenzoyl)- is commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals. It is also used as a reagent in organic synthesis and as a precursor in the production of peptide-based drugs. Additionally, it has been studied for its potential role in the treatment of neurological disorders and as a building block for the development of new materials and bioconjugates.
Check Digit Verification of cas no
The CAS Registry Mumber 526-21-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,2 and 6 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 526-21:
(5*5)+(4*2)+(3*6)+(2*2)+(1*1)=56
56 % 10 = 6
So 526-21-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2O3/c10-7-4-2-1-3-6(7)9(14)11-5-8(12)13/h1-4H,5,10H2,(H,11,14)(H,12,13)
526-21-6Relevant articles and documents
TARGETED DELIVERY TO BETA CELLS
-
, (2018/11/22)
The disclosure includes zinc prodrugs for targeted delivery of therapeutic, diagnostic or imaging agents to β-cells and methods of use therefor. The disclosure also includes targeted delivery of small molecules to β-cells that stabilize and activate CRISP
Application of the 'direct amide cyclization' to peptides containing an anthranilic acid residue
Philipova, Irena,Linden, Anthony,Heimgartner, Heinz
, p. 1711 - 1733 (2007/10/03)
The 2,2-disubstituted 2H-azirin-3-amines 7a-7c were used as amino acid synthons to prepare linear peptides derived from anthranilic acid. These linear peptides, which contain α,α-disubstituted α-amino acids, were synthesized by using the 'azirine/oxazolon
Novel fluorogenic substrates containing bimane system for microdetermination of angiotensin I converting enzyme
Sato,Nishikawa,Kanaoka
, p. 145 - 147 (2007/10/02)
-